Hypothyroidism After the TAVI Procedure in Elderly Patients
Universitair Ziekenhuis Brussel
20 participants
Jul 26, 2021
INTERVENTIONAL
Conditions
Summary
Aortic stenosis is highly prevalent in advancing age. The prognosis of this disease has dramatically changed with the surgical replacement of the aortic valve and the trans catheter aortic valve re-placement (TAVI). The TAVI procedure is also successful in octogenarians and frail patients. However, the evaluation before the TAVI procedure requires a high dosage of iodinated contrast agent with, consequently, an increased risk for thyroid dysfunction. The primary endpoint of this study is to assess, prospectively, the incidence and the predictive factors (underlying thyroid disease, medication, food preservative, topical antiseptics) of hypothyroidism after a TAVI procedure. The secondary endpoint is the influence of the occurrence of hypothyroidism after the TAVI procedure on the geriatric assessment.
Eligibility
Inclusion Criteria3
- Provision of signed and dated, written Informed Consent prior to any study specific proce-dures
- Patient: males and females must be ≥ 70 years old
- Patients who will undergo a TAVI procedure
Exclusion Criteria3
- \- No obtained signed, dated and written Informed Consent.
- Known thyroid dysfunction (for example: Basedow, Hashimoto,...)
- Patients receiving any of the following: Lithium, Strumazol or a recent treatment of radio-Iode
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Blood sample for TSH, fT4, fT3, anti TPO, anti TG thyroid ultra sound Iodine urine sample
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04831957